Related Experiment Video

Updated: Aug 24, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Control of glycaemia: from molecules to men. Minkowski Lecture 2003

M Stumvoll1

  • 13rd Medical Department, University of Leipzig, Philipp-Rosenthal-Str. 27, 04301 Leipzig, Germany. michael.stumvoll@medizin.uni-leipzig.de

Diabetologia
|April 29, 2004
PubMed

Insights

Understanding Type 2 diabetes requires dissecting its complex causes. Novel clinical tools help investigate molecular mechanisms, linking basic science to human physiology for better diabetes management.

Area of Science:

  • Endocrinology and Metabolism
  • Molecular Biology
  • Genetics

Background:

  • Dysregulation of blood glucose (glycaemia) is central to Type 2 diabetes pathogenesis.
  • Type 2 diabetes arises from complex, multifactorial molecular mechanisms, necessitating subphenotype analysis (e.g., non-obese with hepatic steatosis, obese with low adiponectin).
  • The interplay between insulin secretion, insulin sensitivity, and glucose homeostasis provides a pathophysiological framework.

Purpose of the Study:

  • To review novel experimental tools for translating basic science findings into clinical contexts for Type 2 diabetes research.
  • To illustrate the application of these techniques using four key molecules: adiponectin (APM1), stearoyl CoA desaturase-1 (SCD1), insulin receptor substrate-1 (IRS1), and peroxisome proliferator-activated receptor-gamma (PPARG).

Main Methods:

  • Isotope dilution techniques for turnover studies (e.g., glycerol turnover for lipolysis).
  • Clamp procedures (conventional and modified) to assess insulin sensitivity.
  • Genetic association studies analyzing single nucleotide polymorphisms (SNPs) in candidate genes (e.g., IRS1, PPARG).
  • Multivariate correlational analyses (e.g., plasma adiponectin levels).
  • Magnetic resonance spectroscopy for quantifying intra-tissue lipids and fat distribution.
  • Gas chromatography for analyzing fatty acid patterns as indicators of intrahepatic enzyme activity.

Main Results:

  • Selected molecules (APM1, SCD1, IRS1, PPARG) demonstrate plausible roles in Type 2 diabetes pathogenesis.
  • Diverse methodologies effectively probe molecular mechanisms and physiological parameters relevant to glycaemic regulation.
  • These techniques enable the quantification of metabolic processes and genetic predispositions linked to diabetes.

Conclusions:

  • Bridging the gap between basic science and clinical Type 2 diabetes requires interdisciplinary collaboration (genetics, cell biology, physiology, epidemiology).
  • Advanced experimental tools are crucial for dissecting the complex aetiology of Type 2 diabetes and its subphenotypes.
  • A comprehensive understanding of molecular modifiers of glycaemia is essential for developing effective human Type 2 diabetes therapies.

More Related Videos

Simple Continuous Glucose Monitoring in Freely Moving Mice03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Related Concept Videos

Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...